Immunosignaturing can detect products from molecular markers in brain cancer
about
Immunosignature system for diagnosis of cancer.Time-Frequency Analysis of Peptide Microarray Data: Application to Brain Cancer Immunosignatures.The immunosignature of canine lymphoma: characterization and diagnostic applicationImmunosignatures can predict vaccine efficacy.Evaluating biomarkers in melanoma.Identification of non-random sequence properties in groups of signature peptides obtained in random sequence peptide microarray experiments.A General Method to Discover Epitopes from Sera.Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaInteraction of Serum Antibodies from Breast Cancer Patients with Synthetic Peptides.Antibody repertoire profiling with mimotope arrays.Identification of cancer-specific motifs in mimotope profiles of serum antibody repertoireGeneral Assessment of Humoral Activity in Healthy Humans.High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays.Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine.Peptide Microarrays for Medical Applications in Autoimmunity, Infection, and Cancer.Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA.Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines.An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors.Epitope identification from fixed-complexity random-sequence peptide microarrays.Chimeric peptide constructs comprising linear B-cell epitopes: application to the serodiagnosis of infectious diseases.Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope ProteinCould immunosignatures technology enable the development of a preventative cancer vaccine?Immunosignature Differentiation of Non-Infectious Meningoencephalomyelitis and Intracranial Neoplasia in Dogs.
P2860
Q30585860-90CFE7DF-08EF-4185-9442-DD76BB52B4D6Q30979384-F1B321BA-1BF3-4785-9079-7153034A81A2Q34208766-BCEC67B1-DE85-48EC-9481-DE8363C77DADQ34380788-485B4CA0-E5E3-425B-BABC-8813181CB0AAQ35005677-5DC53B1F-511E-41ED-9BDA-8F094B9A4418Q35977617-DDB43031-6932-4160-93E5-313CC0104E35Q36051966-22D6F193-9E7D-4987-926F-0F786417F6F5Q36110293-BDFD1BA4-1349-4879-9CA9-E4F6FB3A903BQ36174786-D4BCB633-55E2-4BF8-8ADE-B82C8A7DD9A8Q36215753-C1A9A84D-70A4-4FEA-8E3E-020568BD0549Q36406087-A2E8559E-BF98-432D-9B58-FDCE1DFE047DQ36876103-96C0E063-3B25-4D9D-B0AC-68DDB1A7E0EAQ37722745-23770A2F-DE12-434C-853F-864020529704Q38068224-DF2F63D6-27A6-47A1-B113-827CB6E38539Q38613536-ECE8BF56-DE41-40A2-AC5A-1473DA689794Q38637954-E51E46A6-EB5E-4CD6-81D0-D60572865851Q39000867-96664DF8-DFED-41BE-9CE5-9E0832051C59Q40057259-2686C0D9-D0F9-47CC-9849-C11297856766Q40184352-4B9A1EB9-3AFB-4180-AE2F-F950DE4B9135Q40622099-8A242971-F183-4DB1-BA23-0BF26DC24FA2Q41921198-006E9327-B136-4ED1-8AF5-676E1D6FB108Q51519843-C4CC0498-29E5-4B7E-8A99-C5ADBE42E4B1Q55093494-F3E004DF-326B-41BE-AAAB-E7DD30F11786
P2860
Immunosignaturing can detect products from molecular markers in brain cancer
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immunosignaturing can detect products from molecular markers in brain cancer
@ast
Immunosignaturing can detect products from molecular markers in brain cancer
@en
Immunosignaturing can detect products from molecular markers in brain cancer
@en-gb
Immunosignaturing can detect products from molecular markers in brain cancer
@nl
type
label
Immunosignaturing can detect products from molecular markers in brain cancer
@ast
Immunosignaturing can detect products from molecular markers in brain cancer
@en
Immunosignaturing can detect products from molecular markers in brain cancer
@en-gb
Immunosignaturing can detect products from molecular markers in brain cancer
@nl
altLabel
Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer
@en
prefLabel
Immunosignaturing can detect products from molecular markers in brain cancer
@ast
Immunosignaturing can detect products from molecular markers in brain cancer
@en
Immunosignaturing can detect products from molecular markers in brain cancer
@en-gb
Immunosignaturing can detect products from molecular markers in brain cancer
@nl
P2093
P2860
P3181
P1433
P1476
Immunosignaturing can detect products from molecular markers in brain cancer
@en
P2093
Alexa K Hughes
Phillip Stafford
Stephen Albert Johnston
Stephen W Coons
Zbigniew Cichacz
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0040201
P407
P577
2012-01-01T00:00:00Z